NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that its fourth quarter revenues rose 3 percent, driven by strong growth in sales within its gynecology surgical and molecular diagnostics businesses.

For the three months ended September 30, the firm reported revenues of $726.8 million up from $702.8 million a year ago, and beating the average consensus Wall Street estimate of $721.7 million. On a constant-currency basis, revenues increased 4 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.